Nerve-Mapping device aims to reduce side effects of rectal cancer surgery
NCT ID NCT04949646
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tests a device that maps pelvic nerves during rectal cancer surgery. The goal is to help surgeons avoid damaging nerves that control bladder, bowel, and sexual function. About 44 adults with rectal cancer will be monitored during surgery and followed for three months to see if their quality of life improves.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Pelvic intraoperative neuromonitoring (pIONM) device
What this could lead to
If it works, this could help preserve bladder, bowel, and sexual function after rectal cancer surgery, improving patients' quality of life.
What could go wrong
This is a small, early-stage study with only 44 participants, so results may not apply to everyone. The monitoring device may not reliably prevent nerve damage.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECTAL CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University Hospital of Larissa
RECRUITINGLarissa, 41110, Greece
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact